With biotechnology taking center stage on several occasions during the past year, President Bush has appointed an 18-member Council of Bioethics to address some of the more controversial aspects of the field. Policy suggestions to emerge from the council are likely to impact the activities of the significant investments many states and localities are making for biotechnology research and seed capital.
The Council will consider a range of bioethical matters connected with specific biomedical and technological activities, such as embryo and stem cell research, assisted reproduction, cloning, uses of knowledge and techniques derived from human genetics or the neurosciences, and end-of-life issues. The Council may also study broader ethical and social issues, such as the protection of human subjects in research and the appropriate uses of biomedical technologies.